Professor Rikard Holmdahl (PhD, MD) has been a professor of medical inflammation research since 1993 (Karolinska Institute, Stockholm since 2008 and Lund University from 1993 to 2007). He has been a professor at the Finnish Academy (Turku University) since 2006. Dr. Holmdahl has a long experience in both academic and entrepreneurial work. He has been leading the work to standardise animal models for autoimmune diseases in Europe and has published more than 500 papers with a strong emphasis on experimental animal work. He is currently a member also of the board of Redoxis subsidiary ProNoxis AB and Vacara AB.